NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.39
+0.38 (1.87%)
Nov 21, 2024, 12:34 PM EST - Market open

NAMS Revenue

NewAmsterdam Pharma Company had revenue of $29.11M in the quarter ending September 30, 2024, with 889.83% growth. This brings the company's revenue in the last twelve months to $33.59M, up 78.77% year-over-year. In the year 2023, NewAmsterdam Pharma Company had annual revenue of $14.09M, down -86.28%.

Revenue (ttm)
$33.59M
Revenue Growth
+78.77%
P/S Ratio
53.68
Revenue / Employee
$1,158,414
Employees
29
Market Cap
1.88B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.09M-88.60M-86.28%
Dec 31, 2022102.69M--
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition